3.9 Article

Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement Summary of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Clinical Practice Guideline Update

Journal

JOURNAL OF ONCOLOGY PRACTICE
Volume 14, Issue 5, Pages 323-+

Publisher

AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JOP.18.00035

Keywords

-

Categories

Funding

  1. Merck
  2. OncoMed
  3. GlaxoSmithKline
  4. Astex Pharmaceuticals
  5. Takeda

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

3.9
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available